{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:56:22Z","timestamp":1762876582321,"version":"3.41.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"DOI":"10.7759\/cureus.87163","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:59:41Z","timestamp":1751464781000},"source":"Crossref","is-referenced-by-count":1,"title":["The Emergence of Subclones Following Initial Chemotherapy in Mixed Phenotype Acute Leukemia"],"prefix":"10.7759","author":[{"given":"Taichi","family":"Murao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Kamitsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081974","article-title":"Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies","volume":"10","author":"George BS","year":"2022","unstructured":"George BS, Yohannan B, Gonzalez A, Rios A. Mixed-phenotype acute leukemia: clinical diagnosis and therapeutic strategies. Biomedicines. 2022, 10:14-6. 10.3390\/biomedicines10081974","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.283","article-title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","volume":"32","author":"Sakura T","year":"2018","unstructured":"Sakura T, Hayakawa F, Sugiura I, et al.. High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG. Leukemia. 2018, 32:626-32. 10.1038\/leu.2017.283","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.202","article-title":"Mixed-phenotype acute leukemia: historical overview and a new definition","volume":"24","author":"Weinberg OK","year":"2010","unstructured":"Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010, 24:1844-51. 10.1038\/leu.2010.202","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes E","year":"2011","unstructured":"Matutes E, Pickl WF, Van't Veer M, et al.. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011, 117:3163-71. 10.1182\/blood-2010-10-314682","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21072","article-title":"A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin","volume":"84","author":"van den Ancker W","year":"2013","unstructured":"van den Ancker W, Westers TM, de Leeuw DC, et al.. A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin. Cytometry B Clin Cytom. 2013, 84:114-8. 10.1002\/cyto.b.21072","journal-title":"Cytometry B Clin Cytom"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12277","article-title":"Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia","volume":"161","author":"Guy J","year":"2013","unstructured":"Guy J, Antony-Debr\u00e9 I, Benayoun E, et al.. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia. Br J Haematol. 2013, 161:551-5. 10.1111\/bjh.12277","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17210","article-title":"Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia","volume":"193","author":"Bras AE","year":"2021","unstructured":"Bras AE, Osmani Z, de Haas V, et al.. Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia. Br J Haematol. 2021, 193:922-7. 10.1111\/bjh.17210","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019493","article-title":"The International Consensus Classification of acute leukemias of ambiguous lineage","volume":"141","author":"Weinberg OK","year":"2023","unstructured":"Weinberg OK, Arber DA, D\u00f6hner H, et al.. The International Consensus Classification of acute leukemias of ambiguous lineage. Blood. 2023, 141:2275-7. 10.1182\/blood.2022019493","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v64.3.701.bloodjournal643701","article-title":"Lineage switch in acute leukemia","volume":"64","author":"Stass S","year":"1984","unstructured":"Stass S, Mirro J, Melvin S, Pui CH, Murphy SB, Williams D. Lineage switch in acute leukemia. Blood. 1984, 64:701-6. 10.1182\/blood.v64.3.701.bloodjournal643701","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13923","article-title":"To B- or not to B-: a review of lineage switched acute leukemia","volume":"44","author":"Kurzer JH","year":"2022","unstructured":"Kurzer JH, Weinberg OK. To B- or not to B-: a review of lineage switched acute leukemia. Int J Lab Hematol. 2022, 44:64-70. 10.1111\/ijlh.13923","journal-title":"Int J Lab Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13988","article-title":"Adult mixed phenotype acute leukemia (MPAL): B\/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes","volume":"45","author":"Weinberg OK","year":"2023","unstructured":"Weinberg OK, Dennis J, Zia H, et al.. Adult mixed phenotype acute leukemia (MPAL): B\/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes. Int J Lab Hematol. 2023, 45:170-8. 10.1111\/ijlh.13988","journal-title":"Int J Lab Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1764369","article-title":"Role of morphology in the diagnosis of acute leukemias: systematic review","volume":"44","author":"Sekar MD","year":"2023","unstructured":"Sekar MD, Raj M, Manivannan P. Role of morphology in the diagnosis of acute leukemias: systematic review. Indian J Med Paediatr Oncol. 2023, 44:464-73. 10.1055\/s-0043-1764369","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/81.3.355","article-title":"The prevalence of hand-mirror cells in acute myeloblastic and lymphoblastic leukemia","volume":"81","author":"Cerezo L","year":"1984","unstructured":"Cerezo L, Head DR, Pullen J, Humphrey B. The prevalence of hand-mirror cells in acute myeloblastic and lymphoblastic leukemia. Am J Clin Pathol. 1984, 81:355-7. 10.1093\/ajcp\/81.3.355","journal-title":"Am J Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.03.012","article-title":"Survival of patients with mixed phenotype acute leukemias: a large population-based study","volume":"39","author":"Shi R","year":"2015","unstructured":"Shi R, Munker R. Survival of patients with mixed phenotype acute leukemias: a large population-based study. Leuk Res. 2015, 39:606-16. 10.1016\/j.leukres.2015.03.012","journal-title":"Leuk Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-551465","article-title":"How I treat mixed-phenotype acute leukemia","volume":"125","author":"Wolach O","year":"2015","unstructured":"Wolach O, Stone RM. How I treat mixed-phenotype acute leukemia. Blood. 2015, 125:2477-85. 10.1182\/blood-2014-10-551465","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi K","year":"2018","unstructured":"Takahashi K, Wang F, Morita K, et al.. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018, 9:2670. 10.1038\/s41467-018-04924-z","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander TB","year":"2018","unstructured":"Alexander TB, Gu Z, Iacobucci I, et al.. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018, 562:373-9. 10.1038\/s41586-018-0436-0","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick K","year":"2014","unstructured":"Patrick K, Wade R, Goulden N, et al.. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol. 2014, 166:421-4. 10.1111\/bjh.12882","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.02.013","article-title":"Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia","volume":"22","author":"Munker R","year":"2016","unstructured":"Munker R, Brazauskas R, Wang HL, et al.. Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia. Biol Blood Marrow Transplant. 2016, 22:1024-9. 10.1016\/j.bbmt.2016.02.013","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.174441","article-title":"Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Munker R","year":"2017","unstructured":"Munker R, Labopin M, Esteve J, Schmid C, Mohty M, Nagler A. Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT. Haematologica. 2017, 102:2134-40. 10.3324\/haematol.2017.174441","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0373-4","article-title":"Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"54","author":"Giebel S","year":"2019","unstructured":"Giebel S, Marks DI, Boissel N, et al.. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2019, 54:798-809. 10.1038\/s41409-018-0373-4","journal-title":"Bone Marrow Transplant"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053190","article-title":"FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors","volume":"8","author":"Neumann M","year":"2013","unstructured":"Neumann M, Coskun E, Fransecky L, et al.. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS One. 2013, 8:e53190. 10.1371\/journal.pone.0053190","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361126-the-emergence-of-subclones-following-initial-chemotherapy-in-mixed-phenotype-acute-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:59:42Z","timestamp":1751464782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361126-the-emergence-of-subclones-following-initial-chemotherapy-in-mixed-phenotype-acute-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.87163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}